SCHEMBL8830678

SCHEMBL8830678

Cc1ccc(-n2c(=O)n(C)c(=O)c3[nH]c(-c4cc(C(C)(C)C)c(O)c(C(C)(C)C)c4)nc32)cc1

nearest known ligand 0.54

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
▸ ADORA2A P29274 3/20 0.47
▸ ADORA2B P29275 3/20 0.47
▸ ADORA1 P30542 2/20 0.44
▸ KDM4E B2RXH2 1/20 0.44
▸ CYP1A2 P05177 1/20 0.44
▸ ADORA3 P0DMS8 1/20 0.44
▸ BLM P54132 1/20 0.44
▸ NPSR1 Q6W5P4 1/20 0.44
▸ HSD17B10 Q99714 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8830649 0.91 ADORA2A (0.47) ADORA2AADORA2BADORA1KDM4ECYP1A2
SCHEMBL8830564 0.91 ADORA2B (0.53) ADORA2AADORA2BADORA1KDM4ECYP1A2
SCHEMBL8830571 0.89 ADORA2B (0.56) ADORA2AADORA2BADORA1KDM4ECYP1A2
SCHEMBL8830674 0.84 PTGS1 (0.40) ADORA2AADORA2B
SCHEMBL9568729 0.84 ADORA2A (0.63) ADORA2AADORA2BADORA1KDM4ECYP1A2
SCHEMBL8830551 0.81 ADORA2B (0.44) ADORA2AADORA2BADORA1KDM4ECYP1A2
SCHEMBL8830756 0.78 ADORA2B (0.57) ADORA2AADORA2BADORA1KDM4ECYP1A2
SCHEMBL8830607 0.76 ADORA2B (0.58) ADORA2AADORA2BADORA1KDM4ECYP1A2
SCHEMBL8830647 0.75 PTGS1 (0.39) ADORA2AADORA2B
SCHEMBL8830563 0.74 PTGS1 (0.40) ADORA2AADORA2BADORA1KDM4ECYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5661153-A FOR TREATING ALLERGIES, ASTHMA, DERMATITIS, GRAFT REJECTIONS JAPAN ENERGY CORPORATION (JP) 1997-08-26 — — US disclosed
EP-0700908-A1 1-Arylpyrimidine derivatives and pharmaceutical use thereof JAPAN ENERGY CORPORATION (JP) 1996-03-13 — — EP disclosed
Send feedback